Protalix BioTherapeutics, Inc.

PLX · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$19,760$23,634$17,111$38,985
Short-Term Investments$15,070$20,926$5,069$0
Receivables$2,909$5,272$4,586$3,442
Inventory$21,243$19,045$16,804$17,954
Other Curr. Assets$1,096$1,055$1,310$1,285
Total Curr. Assets$60,078$69,932$44,880$61,666
Property Plant & Equip (Net)$10,021$10,882$9,640$9,922
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$2,856$3,092$0$0
Other NC Assets$462$528$1,267$2,077
Total NC Assets$13,339$14,502$10,907$11,999
Other Assets$0$0$0$0
Total Assets$73,417$84,434$55,787$73,665
Liabilities
Payables$4,533$4,320$5,862$6,986
Short-Term Debt$1,500$23,069$1,118$1,207
Tax Payable$3,476$2,876$530$0
Deferred Revenue$0$0$13,178$8,550
Other Curr. Liab.$16,112$15,265$11,741$16,433
Total Curr. Liab.$25,621$45,530$32,429$33,176
LT Debt$4,026$4,621$32,356$32,263
Deferred Rev, NC$0$0$0$11,790
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$559$714$1,642$2,472
Total NC Liab.$4,585$5,335$33,998$46,525
Other Liabilities$0$0$0$0
Cap. Leases$5,526$6,030$5,287$5,583
Total Liabilities$30,206$50,865$66,427$79,701
Equity
Pref Stock$0$0$0$0
Common Stock$76$73$54$46
Retained Earnings-$378,393-$381,549-$389,861-$374,934
AOCI$0$0$0$0
Other Equity$421,528$415,045$379,167$368,852
Total Equity$43,211$33,569-$10,640-$6,036
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$73,417$84,434$55,787$73,665
Net Debt-$14,234$4,056$16,363-$5,515